<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03594318</url>
  </required_header>
  <id_info>
    <org_study_id>P13/20_ACR</org_study_id>
    <nct_id>NCT03594318</nct_id>
  </id_info>
  <brief_title>Versailles Hospital Cardiac Arrest Registry</brief_title>
  <official_title>Versailles Hospital Cardiac Arrest Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Versailles Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Versailles Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Out-of-hospital and in-hospital cardiac arrest (CA) requiring intensive care unit management.

      Data collection using a standardized form : demographic data and data related to the CA
      according to the Utstein guidelines.. Circumstances of onset, dates and times of onset and
      control of abnormal movements (myoclonus and.or seizures).

      On-scene clinical findings, pre-hospital and hospital care providers, timing of various
      treatments and supportive care, results of etiological investigations, cause of CA. Dates and
      times of EEG monitoring, EEG results. Outcomes including vital status and Cerebral
      Performance Category scale score at ICU and hospital discharge, day-90 and 1-year after CA
      and determined based on data in the ICU and/or hospital/neurologist charts and/or general
      practitionner phone interview.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 2006</start_date>
  <completion_date type="Anticipated">December 2030</completion_date>
  <primary_completion_date type="Anticipated">December 2026</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>24 Years</target_duration>
  <primary_outcome>
    <measure>Long term favorable outcome</measure>
    <time_frame>1 year</time_frame>
    <description>A favorable outcome is defined by a Cerebral Performance Category scale score (CPC) of 1 or 2. The Cerebral Performance Category scale score will be determined according to hospital charts and/or general practitioner phone interview.
The CPC score : [5: Death, 4: Persistent vegetative state, 3: Severe disability, 2: Moderate disability, 1 : Low disability]</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Short term favorable outcome</measure>
    <time_frame>3 months</time_frame>
    <description>A favorable outcome is defined by a Cerebral Performance Category scale score (CPC) of 1 or 2. The Cerebral Performance Category scale score will be determined according to hospital charts and/or general practitioner phone interview.
The CPC score : [5: Death, 4: Persistent vegetative state, 3: Severe disability, 2: Moderate disability, 1 : Low disability]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postanoxic Status Epilepticus</measure>
    <time_frame>28 days</time_frame>
    <description>Postanoxic Status Epilepticus occurence as defined by EEG abnormalities based on the Salzburg Criteria</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Complications of anticoagulant/ antiplatelet therapies</measure>
    <time_frame>28 days</time_frame>
    <description>Any bleeding requiring &gt;2 Units Red Blood Cell transfusion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short term quality of life as assessed by the Short Form (36) Health Survey (SF36)</measure>
    <time_frame>3 months</time_frame>
    <description>Description of global SF36 score and each of its eight sections (vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning, mental health).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Long term quality of life as assessed by the Short Form (36) Health Survey (SF36)</measure>
    <time_frame>1 year</time_frame>
    <description>Description of global SF36 score and each of its eight sections (vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning, mental health).</description>
  </secondary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Cardiac Arrest</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Cardiac arrest requiring Intensive Care Unit Management
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Cardiac arrest requiring Intensive Care Unit management

          -  Age &gt;= 18 years

        Exclusion Criteria:

        - Refusal to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Legriel Stephane, MD</last_name>
    <role>Study Director</role>
    <affiliation>Intensive care unit</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Legriel Stephane, MD</last_name>
    <email>slegriel@ch-versailles.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CH Versailles</name>
      <address>
        <city>Le Chesnay</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Legriel Stephane, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>July 9, 2018</study_first_submitted>
  <study_first_submitted_qc>July 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 20, 2018</study_first_posted>
  <last_update_submitted>July 18, 2018</last_update_submitted>
  <last_update_submitted_qc>July 18, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 20, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Versailles Hospital</investigator_affiliation>
    <investigator_full_name>LEGRIEL stephane</investigator_full_name>
    <investigator_title>study principal investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Arrest</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

